Name: HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC
Brand: MBL Life Sciences
Availability: InStock

Related products

Shop all

Tetramer/APC - HLA-A*02:01 Mesothelin (20-28) (SLLFLLFSL)MBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-PEMBL Life Sciences$1,610.00

HLA-A*02:01 Negative Tetramer-APCMBL Life Sciences$1,726.00

HLA-A*02:01 Negative Tetramer-BV421MBL Life Sciences$1,726.00

Reviews 0

No reviews have been added for this product.

Reviews

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application	FC
Reactivity	Human
Conjugation	APC
Immunogen	Tyrosinase
Peptide Sequence	YMDGTMSQV
Class	Class I
Sequence Location	368-376
MHC Allele	A*02:01

Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC
Datasheet	HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet

Documents & Links for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC
Datasheet	HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC Datasheet

Citations for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC – 1 Found

Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4. PubMed

Reviews 0

Reviews

HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC

Additional information

Reviews 0

HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC

Additional information

Specifications

Specifications

HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC

Additional information

HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-APC

Additional information

Specifications

Specifications